Newron Pharmaceuticals SPA
22 clinical trials · Sponsor
◉ Watch Newron Pharmaceuticals SPA
| Record | Firm | Date |
|---|---|---|
| Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia (NCT07184619) | Newron Pharmaceuticals SPA | 2026-01-23 |
| Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia (NCT04461119) | Newron Pharmaceuticals SPA | 2020-06-16 |
Track Newron Pharmaceuticals SPA automatically
Every clearance here is in the API, with alerts when new ones post.